DPP-4 inhibitors are commonly used alongside metformin or SGLT-2 inhibitors for additive blood glucose lowering
Classically, three metabolic alterations have been identified that contribute to the development of T2DM: 1) insulin resistance, 2) an eventual decrease in insulin secretion from pancreatic beta cells, and 3) an excess production of glucose from the liver
Individual results vary based on factors like age, baseline hormone levels, lifestyle habits, and adherence to the treatment protocol
The main benefits seen in studies include reduced pain, improved sensation (such as better detection on monofilament tests in people with diabetes), improved nerve signaling in some cases, and reduced swelling in nerves when measured with ultrasound (Effect of Extracorporeal Shockwaves on Diabetic Neuropathic Foot, 2020
How NAD Supports Energy Levels NAD injections offer a comprehensive energy boost by working at the cellular level
This controlled copper delivery enables safe intracellular uptake without the toxic effects of free copper